“We also show that hydroxychloroquine efficiently blocks viral entry mediated by cathepsin L , but not by TMPRSS2, and that a combination of hydroxychloroquine and a clinically-tested TMPRSS2 inhibitor prevents SARS-CoV-2 infection more potently than either drug alone.”